What are the most important unanswered research questions in trial retention? A James Lind Alliance Priority Setting Partnership: The PRioRiTy II (Prioritising Retention in Randomised Trials) study

Dan Brunsdon, Linda Biesty, Peter Brocklehurst, Valerie Brueton, Declan Devane, Jim Elliott, Sandra Galvin, Carrol Gamble, Heidi Gardner, Patricia Healy, Kerenza Hood, Joan Jordan, Doris Lanz, Beccy Maeso, Amanda Roberts, Imogen Skene, Irene Soulsby, Derek Stewart, David Torgerson, Shaun TreweekCaroline Whiting, Sharon Wren, Andrew Worrall, Katie Gillies*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

37 Citations (Scopus)
6 Downloads (Pure)

Fingerprint

Dive into the research topics of 'What are the most important unanswered research questions in trial retention? A James Lind Alliance Priority Setting Partnership: The PRioRiTy II (Prioritising Retention in Randomised Trials) study'. Together they form a unique fingerprint.

Medicine & Life Sciences